Advanced searches left 3/3

Venous Thrombosis - DOAJ

Summarized by Plex Scholar
Last Updated: 08 September 2022

* If you want to update the article please login/register

The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty

Objective Background A prospective clinical review was conducted to determine the safety of the use of lowmolecular-weight heparin in the prevention of deep-vein thrombosis after total knee arthroplasty. The aim of the study: to determine the prevalence of DVT after complete knee osteoarthroplasty and determine the role of low molecular weight heparin in the prevention of this DVT. One group consisted of 12 patients who received no prophylaxis with an anticoagulant, while the other group consisted of 21 patients who were notified of the low-molecular weight heparin 4000 I. U.

Source link: https://doaj.org/article/b44cbc84736e43be850b5b99225cf8d4


Prevalence of thrombophilia in indian patients with deep venous thrombosis – An 8-year single-center study

Thrombophilia is a well-known risk factor for deep venous thrombosis and its recurrence. However, thrombophilia testing aids in determining the duration of anticoagulant therapy. The aim of this research was to determine the incidence of thrombophilia in DVT patients in India. DVT patients with unprovoked DVT, or with recurrent DVT were screened for thrombophilia. The results: One hundred and sixty-six patients were selected for thrombophilia, out of which 163 were males. Conclusion: DVT patients are at a significant risk of recurrence. Although laboratory analysis of thrombophilia is expensive, monitoring therapy in those groups of patients is also important. In our analysis, we discovered thrombophilia in about half of DVT patients aged 60 years old, with unprovoked DVT or with recurrent DVT.

Source link: https://doi.org/10.4103/ijves.ijves_26_22


Catheter Interventions for Acute Deep Venous Thrombosis: Who, When and How

The iliocaval system of selected patients has been shown to have both early and late symptomatic benefit in venous thrombolysis and early recanalization of the iliocaval system. National societies have developed national guidelines recommending early thrombus removal in patients with low bleeding risk and high life expectancy in patients with low bleeding risk and high life expectancy based on the emerging evidence. Surgeons and interventionists may pause and ensure that their patient selection and treatment protocols follow those of current and emerging research as more venous devices become available.

Source link: https://doi.org/10.15420/ver.2019.13


SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia with Venous Thrombosis, Pulmonary Embolism, and Adrenal Haemorrhage: A Case Report with Literature Review

A rare complication of SARS-CoV-2 vaccination with ChAdOx1 and AD26. COV2. S is associated with high mortality in children with venous thrombocytopenia. Vitigation of VITT with the AstraZeneca vaccine compared to the Johnson & Johnson vaccine At present, there are no known differences in the pathophysiology or risk factors of the disease or risk factors of VITT. Five cases of VITT and adrenal bleeding have been identified to date, to date, but the present case was the first to occur after immunization with Johnson & Johnson's vaccine.

Source link: https://doi.org/10.3390/vaccines10040595


A realist evaluation to identify targets to improve the organization of compression therapy for deep venous thrombosis- and chronic venous disease patients.

Although compression therapy is well-established for patients with deep venous thrombosis and chronic venous disease, it is also known that significant differences exist in the clinical practices, which may have a significant effect on patient outcomes. The current research aims to expand our knowledge of the main causes of compression therapy's complex care system and to identify target improvement targets. Results The following are examples from overarching context factors and mechanisms supporting patient satisfaction for compression therapy's success include: empirical evidence-based selection of elastic compression stocking type and class, patient-based selection of assistive devices, individualizing treatment durations for DVT patients, and providing a follow-up for CVD patients. These goals were triggered by factors such as increased health care professionals' willingness, confidence, and encouragement to provide patient-based care, as well as increased patient satisfaction and self-confidence.

Source link: https://doi.org/10.1371/journal.pone.0272566


Relationship between the inflammation/immune indexes and deep venous thrombosis (DVT) incidence rate following tibial plateau fractures

Objectives: Objectives of this research A retrospective review of a prospectively obtained database of patients undergoing tibial plateau fracture surgery between October 2014 and December 2018 was carried out to determine the relationship between inflammation-based indices and deep venous thrombosis incidence rate following tibial plateau fractures. Ultrasonography of Duplex Ultrasonography was used routinely to look for preoperative DVT of bilateral lower extremities. To determine the optimal cutoff value for each variable, the receiver operating characteristic was used. Among the 1179 patients evaluated, 16. 3% of them had a preoperative DVT, which was 16. 3% of the patients. In the sensitivity analysis with open fractures excluded, the other independent variables were increased D-dimer level, male gender, and hypertension. Conclusion These identified risk factors are likely to the initial screening for patients at risk of DVT, personalized risk assessment, risk stratification, and, ultimately, the establishment of targeted prevention services.

Source link: https://doi.org/10.1186/s13018-020-01765-9


Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19

In the last three years, COVID-19 pandemic has had major effects on global populations in terms of health and social cost. Pneumonia is just one of many pathologies related to COVID-19 disease. We present a case of CVT in a patient affected by COVID, which is a few months before.

Source link: https://doi.org/10.3390/diagnostics12051253


Atherosclerosis and Its Impact on the Outcomes of Patients with Deep Venous Thrombosis

We wanted to investigate the effect of atherosclerosis on patients with deep venous thrombosis and to determine the differences between DVT patients with and without PE. Patients with DVT with and without symptomatic atherosclerosis, as well as with and without PE under oral anticoagulation were enrolled in January 2011-2013. The symptomatic atherosclerosis patients with symptomatic atherosclerosis were older, more prevalent male, and had a greater incidence of classical CVRF and a higher Charlson comorbidity index. Patients without PE had diabetes mellitus and symptomatic atherosclerosis more often than DVT patients with PE, and symptomatic atherosclerosis was associated with isolated DVT. Conclusions: Atherosclerosis was correlated with isolated DVT and increased mortality in DVT patients under oral anticoagulation. Patients with and without a concomitant PE varied between DVT patients with and without a concomitant PE.

Source link: https://doi.org/10.3390/life12050734


Incidence and risk factors of preoperative deep venous thrombosis following pelvic and acetabular fractures: a retrospective case–control study

DVT causes and causes (the purpose of this research was to determine the occurrence of deep venous thrombosis in the pelvic cavity and lower extremities following pelvic and acetabular fractures, as well as the risk factors for the occurrence of DVT. Patients enrolled in Duplex ultrasound screening and blood testing were performed from June 2012 to December 2020 for surgical treatment of pelvic and acetabular fractures. Using the receiver operating characteristic curve, the optimal cutoff values of continuous variables with statistical significance were found. A total of 607 patients with pelvic and acetabular fractures were included, out of whom 82 patients experienced postoperative DVTs. Despite the new prophylactic regimen, orthopaedic surgeons' fascination with patients with pelvic and acetabular fractures has remained high. These risk factors can help surgeons refine the risk stratification profile and implement early interdisciplinary care for patients at high risk of DVT.

Source link: https://doi.org/10.1186/s13018-022-02972-2


Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database

However, there have been no reports of correlations between COVID-19 mRNA vaccination and CVT. A disproportionality analysis was carried out regarding COVID-19 mRNA vaccines and the ChAdOx1 nCoV-19 vaccine. We discovered 756 CVT cases of 1,154,023 mRNA vaccine-related ADRs in 2007. For COVID-19 mRNA vaccines, significant positive safety results were recorded. The median days to CVT vaccination onset differed significantly between the BNT162b2 and ChAdOx1 nCov-19 vaccines. Fewer CVT patients died after getting mRNA vaccines than after receiving the ChAdOx1 nCoV-19 vaccine. After COVID-19 mRNA vaccination, we found a potential safety warning for CVT outbreaks.

Source link: https://doi.org/10.3390/vaccines10050799

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions